UK Trade and Investment Joins Hands with Randox

Randox Laboratories Ltd. UK in association with UK Trade and Investment Pakistan organized seminars in Karachi, Lahore and Islamabad from 22nd to 24th May, on “Improving Healthcare and Laboratory performance in Pakistan.”

The seminars were targeted to the pathologists and lab professionals of private and public hospitals in Pakistan.

Stephen Doherty, a representative of Randox Laboratories Ltd, was the key note speaker with his main topic of discussion being how hospitals and laboratories in Pakistan can improve patients’ results reported by the clinical laboratories through External Quality Assurance and Internal Quality Control.

Dr. Adnan Zuberi, a Consultant Chemical Pathologist at Ziauddin University Hospital, also was one of the speaker’s during the seminars who discussed the cost saving benefits of early errors detection and correct patient diagnosis.

Randox Laboratories Ltd was established in 1982 in the UK and for over 30 years they have played a pioneering role in healthcare. Today, as a world leader in in-vitro diagnostics, they supply a wide range of diagnostic instruments and tests for rapid and reliable disease detection.

Randox have been distributing in Pakistan through Muslim Trading for almost 25 years and have established business with both public and private sector healthcare customers.

British Deputy High Commissioner and Director UK Trade and Investment, Pakistan, Francis Campbell said: “We are very pleased to organize these seminars with Randox to improve healthcare system in Pakistan. UK Trade and Investment’s main role in Pakistan is to help British business grow and Randox’s success in this market sets up a fine example of successful British companies operating in Pakistan.”